Rogula, S.; Błażejowska, E.; Gąsecka, A.; Szarpak, Ł.; Jaguszewski, M.J.; Mazurek, T.; Filipiak, K.J.
Inclisiran—Silencing the Cholesterol, Speaking up the Prognosis. J. Clin. Med. 2021, 10, 2467.
https://doi.org/10.3390/jcm10112467
AMA Style
Rogula S, Błażejowska E, Gąsecka A, Szarpak Ł, Jaguszewski MJ, Mazurek T, Filipiak KJ.
Inclisiran—Silencing the Cholesterol, Speaking up the Prognosis. Journal of Clinical Medicine. 2021; 10(11):2467.
https://doi.org/10.3390/jcm10112467
Chicago/Turabian Style
Rogula, Sylwester, Ewelina Błażejowska, Aleksandra Gąsecka, Łukasz Szarpak, Milosz J. Jaguszewski, Tomasz Mazurek, and Krzysztof J. Filipiak.
2021. "Inclisiran—Silencing the Cholesterol, Speaking up the Prognosis" Journal of Clinical Medicine 10, no. 11: 2467.
https://doi.org/10.3390/jcm10112467
APA Style
Rogula, S., Błażejowska, E., Gąsecka, A., Szarpak, Ł., Jaguszewski, M. J., Mazurek, T., & Filipiak, K. J.
(2021). Inclisiran—Silencing the Cholesterol, Speaking up the Prognosis. Journal of Clinical Medicine, 10(11), 2467.
https://doi.org/10.3390/jcm10112467